Givaudan | GIVN - Equity Capital And Reserves



Givaudan reported CHF4.31B in Equity Capital and Reserves for its fiscal semester ending in June of 2024.


Equity Capital And Reserves Change Date
Air Liquide EUR 24.51B 3.11B Jun/2025
Akzo Nobel EUR 4.17B 452M Jun/2025
Anheuser-Busch USD 91.41B 13.18B Jun/2025
Arkema EUR 6.13B 1.23B Jun/2025
Associated British Foods GBP 11B 191M Mar/2025
BASF EUR 32.36B 3.73B Jun/2025
Bayer EUR 30.5B 2.08B Jun/2025
Beiersdorf EUR 8.47B 7M Jun/2025
British American Tobacco GBP 54.47B 1.9B Jun/2024
Covestro EUR 6.15B 255M Jun/2025
Croda International GBP 2.28B 53.3M Dec/2024
Danone EUR 15.36B 2.43B Jun/2025
Diageo GBP 13.18B 2.89B Jun/2025
Fresenius EUR 18.94B 465M Jun/2025
Fresenius Medical Care EUR 14.33B 1.18B Jun/2025
Givaudan CHF 4.31B 320M Jun/2024
Glanbia USD 2.07B 78.6M Jan/2025
Heineken EUR 17.71B 1.87B Jun/2025
Henkel EUR 20.04B 1.7B Jun/2025
International Flavors Fragrances USD 14.4B 1.19B Jun/2025
Johnson Matthey GBP 2.3B 125M Mar/2025
Kerry EUR 6.49B 27M Dec/2024
Lonza CHF 9.33B 23M Dec/2024
L'Oréal EUR 31.18B 1.96B Jun/2025
Merck EUR 28.26B 1.64B Jun/2025
Nestle CHF 28.83B 7.09B Jun/2025
Pernod Ricard EUR 16.54B 254M Dec/2024
Reckitt Benckiser GBP 6.7B 1.39B Dec/2024
SGS CHF 877M 188M Dec/2024
Sika AG CHF 7.05B 621.6M Dec/2024
Solvay EUR 1.2B 156M Jun/2025
Tate & Lyle GBP 1.59B 396M Mar/2025
Umicore EUR 2.04B 105.8M Jun/2025
Victrex 434.8M 26.2M Mar/2025